Developmental reflexes and 31P Magnetic Resonance Spectroscopy of basal ganglia in antipsychotic-naive schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 5, 2006, Pages 910-913

  Gangadhar, Bangalore N ^a   Jayakumar, Peruvamba N ^a   Venkatasubramanian, Ganesan ^a   Janakiramaiah, Nimmagadda ^a   Keshavan, Matcheri S ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Basal ganglia; Magnetic Resonance Spectroscopy; Schizophrenia

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BASAL GANGLION; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HIGH ENERGY PHOSPHATE; HUMAN; IN VIVO STUDY; MALE; METABOLIC DISORDER; NERVE CELL DIFFERENTIATION; ONSET AGE; PHOSPHATE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PSYCHOSIS; REFLEX; SCHIZOPHRENIA; CHEMISTRY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ADENOSINE TRIPHOSPHATE; ADULT; BASAL GANGLIA; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHOSPHOCREATINE; PSYCHIATRIC STATUS RATING SCALES; REFLEX; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 33646930451     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.02.003     Document Type: Article

References (34)

1. American Psychiatric Association. DSM-IV: diagnostic and statistical manual of mental disorders. Fourth ed. (1994), American Psychiatric Association, Washington (DC)
2. Annett M. The binomial distribution of right mixed and left-handedness. Q J Exp Psychol 19 (1967) 327-333
3. Ben-Shachar D. Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem 83 (2002) 1241-1251
4. Ben-Shachar D., and Laifenfeld D. Mitochondria, synaptic plasticity, and schizophrenia. Int Rev Neurobiol 59 (2004) 273-296
5. Bradshaw J.L., and Sheppard D.M. The neurodevelopmental frontostriatal disorders: evolutionary adaptiveness and anomalous lateralization. Brain Lang 73 (2000) 297-320
6. Buchanan R.W., and Heinrichs D.W. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res 27 (1989) 335-350
7. Chirichigno J., Manfredi G., Beal M., and Albers D. Stress-induced mitochondrial depolarization and oxidative damage in PSP cybrids. Brain Res 951 (2002) 31-35
8. Corti O., Hampe C., Darios F., Ibanez P., Ruberg M., and Brice A. Parkinson's disease: from causes to mechanisms. C R Biol 328 2 (2005) 131-142
9. Dazzan P., and Murray R.M. Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry Suppl 43 (2002) s50-s57
10. Dazzan P., Morgan K.D., Orr K.G., Hutchinson G., Chitnis X., Suckling J., et al. The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain 127 (2004) 143-153
11. Eyles D.W., Pond S.M., Van der Schyf C.J., and Halliday G.M. Mitochondrial ultrastructure and density in a primate model of persistent tardive dyskinesia. Life Sci 66 (2000) 1345-1350
12. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured clinical interview for DSM-IV Axis I disorders: user's guide (1997), American Psychiatric Press, New York
13. 31P Magnetic Resonance Spectroscopic study of Basal Ganglia in drug naive first episode schizophrenia. Am J Psychiatry 161 (2004) 1304-1306
14. Goldberg D.P., Gater R., Sartorius N., Ustun T.B., Piccinelli M., Gureje O., et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 27 1 (1997) 191-197
15. Hafner H., Riecher-Rossler A., Hambrecht M., Maurer K., Meissner S., Schmidtke A., et al. IRAOS: an instrument for the Retrospective Assessment of the Onset of Schizophrenia. Schizophr Res 6 (1992) 209-223
16. Huber S.J., and Paulson G.W. Influence of dopamine and disease severity on primitive reflexes in Parkinson's disease. Eur Neurol 29 3 (1989) 141-144
17. 31P MRS study. Biol Psychiatry 54 (2003) 491-494
18. Kay S.R., Fizbein A., and Opler A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 2 (1987) 261-276
19. Keshavan M.S. Neurodevelopment and schizophrenia: quo vadis?. In: Keshavan M.S., and Murray R.M. (Eds). Neurodevelopment and adult psychopathology (1997), Cambridge University Press, London 267-277
20. Klushnik T.P., Spunde A.Y., Yakovlev A.G., Khuchua Z.A., Saks V.A., and Vartanyan M.E. Intracellular alterations of the creatine kinase isoforms in brains of schizophrenic patients. Mol Chem Neuropathol 15 3 (1991) 271-280
21. Kung L., and Roberts R.C. Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study. Synapse 31 1 (1999) 67-75
22. Maurer I., Zierz S., and Moller H. Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res 48 1 (2001) 125-136
23. Ossowska K. Neuronal basis of neuroleptic-induced extrapyramidal side effects. Pol J Pharmacol 54 (2002) 299-312
24. Pogue-Geile M.F. Developmental aspects of schizophrenia. In: Keshavan M.S., and Murray R.M. (Eds). Neurodevelopment and adult psychopathology (1997), Cambridge University Press, London 137-154
25. Schore A.N. Early organization of the nonlinear right brain and development of a predisposition to psychiatric disorders. Dev Psychopathol 9 4 (1997) 595-631
26. Schott J.M., and Rossor M.N. The grasp and other primitive reflexes. J Neurol Neurosurg Psychiatry 74 (2003) 558-560
27. Schroder J., Silvestri S., Bubeck B., Karr M., Demisch S., Scherrer S., et al. D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment. Biol Psychiatry 43 9 (1998) 660-665
28. Shoffner J.M. Mitochondrial defects in basal ganglia diseases. Curr Opin Neurol 8 6 (1995) 474-479
29. Snowden M.B., Bowden J.D., Hughes J., and Larson E.B. Study of Alzheimer's dementia patients with parkinsonian features. J Geriatr Psychiatry Neurol 8 3 (1995) 154-158
30. Venkatasubramanian G., Gangadhar B.N., Janakiramaiah N., Subbakrishna D.K., Jayakumar P.N., and Keshavan M.S. Increased neurological soft signs in never-treated, younger age at onset schizophrenia. Biol Psychiatry 51 (2002) 175S
31. Venkatasubramanian G., Latha V., Gangadhar B.N., Janakiramaiah N., Subbakrishna D.K., Jayakumar P.N., et al. Neurological soft signs in never-treated schizophrenia. Acta Psychiatr Scand 108 (2003) 144-146
32. Vreeling F.W., Verhev F.R., Houx P.J., and Jolles J. Primitive reflexes in Parkinson's disease. J Neurol Neurosurg Psychiatry 56 12 (1993) 1323-1326
33. Yao J.K., Reddy R.D., and van Kammen D.P. Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 15 4 (2001) 287-310
34. Youssef H.A., and Waddington J.L. Primitive (developmental) reflexes and diffuse cerebral dysfunction in schizophrenia and bipolar affective disorder: overrepresentation in patients with tardive dyskinesia. Biol Psychiatry 23 8 (1988) 791-796